Anika Therapeutics, Inc. ( ANIK) - Key Metrics
ANIK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.14 | $0.02 | $0.32 | $0.28 |
| 2025Q3 | $1.94 | -$0.16 | $0.48 | $0.35 |
| 2025Q2 | $1.97 | -$0.28 | -$0.01 | -$0.12 |
| 2025Q1 | $1.83 | -$0.34 | -$0.01 | -$0.21 |
ANIK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 117.43 |
| 2025Q3 | ? | -14.49 |
| 2025Q2 | ? | -9.55 |
| 2025Q1 | ? | -11.02 |
ANIK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -3.20% | ? |
| 2025Q4 | 2.91% | ? |
| 2025Q3 | 3.68% | ? |
| 2025Q2 | -1.09% | ? |
| 2025Q1 | -1.37% | ? |
ANIK
Price: $15.16
52 week price:
Earnings Per Share: -0.79 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 53407
Ebitda: 11.5 millionMarket Capitalization: 204.4 million